Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

Compass Pathways gains Stifel's Buy rating as its COMP360 psilocybin treatment advances in Phase 3 trials. Key depression ...

Escalating concerns over impending tariffs and President Trump's foreign policies have fueled uncertainty and instability in ...

The diagnosis of major depressive disorder is based on the patient's self-reported experiences, behavior reported by relatives or friends, and a mental status examination. There is no laboratory ...

Major Depressive Disorder, and Persistent Depressive Disorder. These reports include a comprehensive understanding of current treatment practices, emerging drugs, market share of individual ...

Ketamine can effectively treat depression, but whether depressed patients with alcohol use disorder can safely use ketamine ...

Ketamine can effectively treat depression, but whether depressed patients with alcohol use disorder can safely use ketamine repeatedly remains unclear clinically.